Back to search

Article

Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with Metabolically Dysfunction Associated Steatotic Liver Disease

2026-01-11

Abstract excerpt

<h4>Introduction and Objectives:</h4> Metabolic dysfunction-associated steatotic liver disease (MASLD) affects about one-quarter of adults worldwide, and liver fibrosis is its strongest predictor of liver-related morbidity and mortality. Using combined in-silico screening and clinical validation, we aimed to identify circulating biomarkers associated with fibrosis progression. Fibulin-3 was identified, and its d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0639df52-79ec-5114-876f-cd872e56c7a5
DOI
10.64898/2026.01.08.26343687
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with Metabolically Dysfunction Associated Steatotic Liver DiseaseDOI 10.64898/2026.01.08.26343687
Global molecular landscape of early MASLD progression in obesitySemantic proximity
Profiling the genome and proteome of metabolic dysfunction-associated steatotic liver disease identifies potential therapeutic targetsSemantic proximity
An integrated proteogenomic investigation of the human liver uncovers molecular drivers of steatotic liver diseaseSemantic proximity
Clinical and genetic risk factors for progressive fibrosis in metabolic dysfunction–associated steatotic liver diseaseSemantic proximity
A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liverSemantic proximity
A novel gene signature to diagnose MASLD in metabolically unhealthy obese individualsSemantic proximity
A proteo-transcriptomic map of non-alcoholic fatty liver disease signaturesSemantic proximity
A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severitySemantic proximity
Integrative proteo-transcriptomic characterization of advanced fibrosis in chronic liver disease across etiologiesSemantic proximity
AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver disease.Semantic proximity
Molecular characterization of liver steatosis through circulating proteins, metabolites and lipidsSemantic proximity
UK Biobank-Based Genetic and Proteomic Network Insights into Metabolic Dysfunction-Associated Steatotic Liver Disease Pathogenesis.Semantic proximity
Select a neighboring publication to make it the new centre.